Zhi Cheng Wen
Director/Board Member at Zhuhai Ebang Pharmaceutical Co. Ltd.
Net worth: 16 M $ as of 2024-04-29
Profile
Zhi Cheng Wen is currently a Director at Zhuhai Ebang Pharmaceutical Co. Ltd.
He previously worked as a Director at Youngy Health Co., Ltd.
and as a Vice President at Kunwu Jiuding Capital Co. Ltd.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-09-24 | 11,822,970 ( 10.69% ) | 11 M $ | 2024-04-29 | |
2023-09-24 | 5,059,039 ( 6.70% ) | 5 M $ | 2024-04-29 |
Zhi Cheng Wen active positions
Companies | Position | Start |
---|---|---|
Zhuhai Ebang Pharmaceutical Co. Ltd. | Director/Board Member | 2011-07-24 |
Former positions of Zhi Cheng Wen
Companies | Position | End |
---|---|---|
YOUNGY HEALTH CO., LTD. | Director/Board Member | 2013-12-21 |
Kunwu Jiuding Capital Co. Ltd.
Kunwu Jiuding Capital Co. Ltd. Investment ManagersFinance Kunwu Jiuding Capital Co. Ltd. (Jiuding Capital) is the private equity subsidiary of Beijing Tongchuang Jiuding Investment Mgt Holding Co. Ltd. in China. Founded by Xiaojie Huang in 2007, the firm was formerly known as Beijing Huida Jiuding Capital Co., Ltd., and changed their name to Kunwu Jiuding Capital Co. Ltd. in 2008. They are based in Beijing and manage the Jiuding Private Equity Funds, focusing primarily on pre-IPO investments. | Corporate Officer/Principal | - |
Experiences
Positions held
Linked companies
Listed companies | 1 |
---|---|
YOUNGY HEALTH CO., LTD. | Consumer Services |
Private companies | 2 |
---|---|
Kunwu Jiuding Capital Co. Ltd.
Kunwu Jiuding Capital Co. Ltd. Investment ManagersFinance Kunwu Jiuding Capital Co. Ltd. (Jiuding Capital) is the private equity subsidiary of Beijing Tongchuang Jiuding Investment Mgt Holding Co. Ltd. in China. Founded by Xiaojie Huang in 2007, the firm was formerly known as Beijing Huida Jiuding Capital Co., Ltd., and changed their name to Kunwu Jiuding Capital Co. Ltd. in 2008. They are based in Beijing and manage the Jiuding Private Equity Funds, focusing primarily on pre-IPO investments. | Finance |
Zhuhai Ebang Pharmaceutical Co. Ltd. |
- Stock Market
- Insiders
- Zhi Cheng Wen